Concepedia

Brett Ewald

BE

Statistics

Publications

16

Citations

1.9K

H-Index

15

Active since

2005

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University of Newcastle Australia

DNAtrix (United States)

Novartis (United States)

University of Toronto

Brett Ewald is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and molecular oncology.

Publications per year

2005–2022

16

Publications

16

Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma

Frederick F. Lang, Charles A. Conrad, Candelaria Gomez‐Manzano et al. · Journal of Clinical Oncology · 2018 · 708 citations

, , +17

Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma

Jaime Gállego Pérez‐Larraya, Marc García-Moure, Sara Labiano et al. · New England Journal of Medicine · 2022 · 262 citations · Full text

, , +15

H2AX phosphorylation marks gemcitabine-induced stalled replication forks and their collapse upon S-phase checkpoint abrogation

Brett Ewald, Deepa Sampath, William Plunkett · Molecular Cancer Therapeutics · 2007 · 216 citations

, , +17

Cohort Profile: The Hunter Community Study

Mark McEvoy, Wayne Smith, Catherine D’Este et al. · International Journal of Epidemiology · 2010 · 119 citations · Full text

, , +11

A phase 1 study of lucatumumab, a fully human anti‐<scp>CD</scp>40 antagonist monoclonal antibody administered intravenously to patients with relapsed or refractory multiple myeloma

William Bensinger, Richard T. Maziarz, Sundar Jagannath et al. · British Journal of Haematology · 2012 · 108 citations · Full text

, , +17

1–5 of 16